Effects of Low-Dose Medium-Chain Triglycerides on Bowel Habit Outcomes in Japanese Adults Prone to Constipation: A Randomized, Double-Blind, LCT-Controlled Crossover Trial

Why It Matters

Improving bowel regularity with a small, safe dietary addition could reduce constipation‑related health risks and boost quality‑of‑life, offering a low‑cost functional‑food solution for a large segment of the Japanese population.

Key Takeaways

• 2 g daily MCT increased days with bowel movements
• Significant gains in stool volume observed versus LCT
• No adverse events reported for low-dose MCT
• Subjective abdominal VAS scores improved similarly for MCT and LCT
• Crossover design eliminated sequence effects, confirming true diet impact

Pulse Analysis

Constipation affects over a third of Japanese adults, contributing to reduced productivity, lower quality of life, and heightened cardiovascular risk. Traditional remedies range from fiber supplements to prescription laxatives, yet many consumers seek milder, nutrition‑based options. Medium‑chain triglycerides, long used in clinical nutrition for malabsorption disorders, have a unique metabolic pathway that bypasses conventional fat digestion, prompting interest in their potential to stimulate intestinal motility without harsh side effects.

The recent Frontiers in Nutrition study employed a rigorous double‑blind, LCT‑controlled crossover design, enrolling 82 participants who habitually experienced three to five bowel movements per week. Over two‑week periods, participants consumed 2 g of MCT or LCT daily, with a washout interval to mitigate carry‑over effects. Linear mixed‑effects modeling revealed statistically significant diet effects for days with bowel movements, frequency, and stool volume, while subjective abdominal VAS scores improved during both phases but did not differ between oils. Importantly, the low‑dose MCT regimen was well tolerated, with no supplement‑related adverse events, underscoring its safety profile for everyday use.

These findings position low‑dose MCT as a viable functional ingredient for constipation‑prone consumers, especially those wary of high‑dose supplements or pharmaceutical laxatives. Food manufacturers can incorporate modest MCT quantities into snack bars, beverages, or fortified dairy products to deliver measurable bowel‑movement benefits. Future research should explore long‑term outcomes, dose‑response relationships, and synergistic effects with dietary fiber, paving the way for evidence‑based recommendations that align with consumer demand for natural, gut‑friendly solutions.